布地奈德联合复方异丙托溴铵溶液雾化吸入治疗小儿支气管哮喘临床研究  

Clinical research of Budesonide combined with Compound Ipratropium Bromide aerosol inhalation in the treatment of children with bronchial asthma

作　　者：李君[1] LI Jun(Department of Pediatrics,The First People＇s Hospital of Benxi Conty in Benxi City,Benxi 117100,China)

机构地区：[1]辽宁省本溪市本溪县第一人民医院儿科,117100

出　　处：《中国现代药物应用》2018年第17期70-71,共2页Chinese Journal of Modern Drug Application

摘　　要：目的探讨布地奈德联合复方异丙托溴铵雾化吸入治疗小儿支气管哮喘的临床疗效。方法 80例小儿支气管哮喘患儿,按照就诊时间分为对照组与研究组,每组40例。两组均实施常规治疗,对照组患儿给予布地奈德雾化吸入治疗,研究组患儿给予布地奈德联合复方异丙托溴铵溶液雾化吸入治疗。比较两组患儿咳嗽消失时间、肺部湿啰音消失时间、肺部哮鸣音消失时间及临床疗效。结果研究组患儿咳嗽消失时间、肺部湿啰音消失时间、肺部哮鸣音消失时间均短于对照组,差异具有统计学意义(P<0.05)。研究组患儿总有效率为97.50%,高于对照组的80.00%,差异具有统计学意义(P<0.05)。结论小儿支气管哮喘采用布地奈德联合复方异丙托溴铵雾化吸入治疗的效果更为理想。Objective To investigate the clinical effect of Budesonide combined with Compound Ipratropium Bromide aerosol inhalation in the treatment of children with bronchial asthma. Methods A total of 80 children with bronchial asthma were divided into control group and research group according to the time of visit, 40 cases in each group. The two groups were given conventional therapy, children in the control group were given Budesonide aerosol inhalation therapy, children in the research group were given Budesonide combined with Compound Ipratropium Bromide aerosol inhalation therapy. The disappearance times of cough, pulmonary moist rales and pulmonary wheezing rales, its clinical efficacy between the two groups were compared. Results The disappearance times of cough, pulmonary moist rales and pulmonary wheezing rales in the research group were significantly shorter than those in the control group, the differences were statistically significant（P〈0.05）. The total effective rate of the research group was 97.50%, which was significantly higher than 80.00% of the control group, the difference was statistically significant（P〈0.05）. Conclusion The effect of Budesonide combined with Compound Ipratropium Bromide aerosol inhalation in the treatment of children with bronchial asthma is more ideal.

关 键 词：小儿支气管哮喘 布地奈德 复方异丙托溴铵 雾化吸入 

分 类 号：R725.6[医药卫生—儿科]